Atlas Trials

A Bioequivalence Study of Advil PM Liqui-Gels Minis (Ibuprofen/Diphenhydramine Hydrochloride 200 mg/25 mg) Compared to the Current Marketed Advil PM Liqui-Gels (Ibuprofen/Diphenhydramine Hydrochloride 200 mg/25 mg) in Healthy Adult Subjects Under Fasted Conditions

Clinical trial NCT05674721 · COMPLETED

Trial details

NCT number
NCT05674721
Sponsor
HALEON
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pain
Start date
2023-01-05
Primary completion
2023-03-21
Enrollment
77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.